ATE203990T1 - Indolderivat als 5-ht1a antagonist und als inhibitor der serotonin-wiederaufnahme - Google Patents

Indolderivat als 5-ht1a antagonist und als inhibitor der serotonin-wiederaufnahme

Info

Publication number
ATE203990T1
ATE203990T1 AT97304280T AT97304280T ATE203990T1 AT E203990 T1 ATE203990 T1 AT E203990T1 AT 97304280 T AT97304280 T AT 97304280T AT 97304280 T AT97304280 T AT 97304280T AT E203990 T1 ATE203990 T1 AT E203990T1
Authority
AT
Austria
Prior art keywords
inhibitor
serotonin reuptake
serotonin
indole derivative
ht1a antagonist
Prior art date
Application number
AT97304280T
Other languages
English (en)
Inventor
Daniel James Koch
Vincent Patrick Rocco
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Application granted granted Critical
Publication of ATE203990T1 publication Critical patent/ATE203990T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
AT97304280T 1996-06-20 1997-06-18 Indolderivat als 5-ht1a antagonist und als inhibitor der serotonin-wiederaufnahme ATE203990T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US2013196P 1996-06-20 1996-06-20

Publications (1)

Publication Number Publication Date
ATE203990T1 true ATE203990T1 (de) 2001-08-15

Family

ID=21796938

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97304280T ATE203990T1 (de) 1996-06-20 1997-06-18 Indolderivat als 5-ht1a antagonist und als inhibitor der serotonin-wiederaufnahme

Country Status (12)

Country Link
US (1) US5912256A (de)
EP (1) EP0814084B1 (de)
JP (1) JP2000513358A (de)
AT (1) ATE203990T1 (de)
AU (1) AU3401797A (de)
CA (1) CA2257962A1 (de)
DE (1) DE69706000T2 (de)
DK (1) DK0814084T3 (de)
ES (1) ES2160894T3 (de)
GR (1) GR3037072T3 (de)
PT (1) PT814084E (de)
WO (1) WO1997048698A1 (de)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6399618B1 (en) 1997-07-09 2002-06-04 Cardiome Pharma Corp Compositions and methods for modulating sexual activity
US6310066B1 (en) 1998-04-29 2001-10-30 American Home Products Corp. Antipsychotic indolyl derivatives
WO1999055672A2 (en) * 1998-04-29 1999-11-04 American Home Products Corporation Antipsychotic indolyl derivatives
AU746887B2 (en) * 1998-09-15 2002-05-02 Eli Lilly And Company Treatment of persistent pain
FR2788772B1 (fr) * 1999-01-26 2001-03-02 Adir Nouveaux composes cyano-indoles inhibiteurs de recapture de serotonine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
JP3893878B2 (ja) 1999-05-24 2007-03-14 三菱ウェルファーマ株式会社 フェノキシプロピルアミン化合物
AR021155A1 (es) * 1999-07-08 2002-06-12 Lundbeck & Co As H Tratamiento de desordenes neuroticos
EP1671628B1 (de) * 1999-09-03 2012-10-03 APBI Holdings, LLC Selektive Serotonin-Aufnahme Inhibitoren mit schnellem Wirkungseintritt zur Behandlung von sexueller Dysfunktionen
WO2001022941A1 (en) * 1999-09-28 2001-04-05 H. Lundbeck A/S Melt granulated composition and modified release dosage form prepared from said composition
FR2799463B1 (fr) * 1999-10-12 2004-04-16 Adir Nouveaux composes cyano-indoles inhibiteurs de recapture de serotonine, leur procede de preparation et ces compositions pharmaceutiques qui les contiennent
AU1018801A (en) * 1999-10-29 2001-05-14 Novo Nordisk A/S Use of 3,4-substituted piperidines
EP1242419A1 (de) * 1999-12-20 2002-09-25 Eli Lilly And Company Azabicyclo[3.2.1]octane derivate
WO2001046179A1 (en) * 1999-12-20 2001-06-28 Eli Lilly And Company Piperidine derivatives and their use as serotonin receptor antagonists
EP1242411B1 (de) * 1999-12-20 2006-03-08 Eli Lilly And Company Indolderivate zur behandlung von depression und angstzuständen
UA76130C2 (en) * 2000-11-20 2006-07-17 Merck Patent Gmbh Use of compounds combining properties of selective inhibitors of serotonin re-uptake and agonists of 5-ht1a receptor for treatment of irritable bowel syndrome
DE10117184A1 (de) * 2001-04-05 2002-10-17 Gruenenthal Gmbh Substituierte Imidazol[1,2-a]-pyridin-3-yl-amid- und -aminverbindungen
TW589312B (en) 2001-05-25 2004-06-01 Wyeth Corp Aryl-8-azabicyclo[3.2.1]octanes for the treatment of depression
US6602911B2 (en) * 2001-11-05 2003-08-05 Cypress Bioscience, Inc. Methods of treating fibromyalgia
WO2003068211A1 (en) * 2002-02-12 2003-08-21 Cypress Bioscience, Inc. Methods of treating attention deficit/hyperactivity disorder (adhd)
RU2340333C2 (ru) * 2002-08-15 2008-12-10 Вайет Агонизм 5нт2a -рецептора для лечения нарушения функции терморегуляции
JP2006504795A (ja) * 2002-10-03 2006-02-09 サイプレス バイオサイエンス, インコーポレイテッド 神経学的障害を処置するための抗うつ剤の投薬量の段階的な漸増ならびに毎日の分割した投薬
US7417064B2 (en) 2002-11-05 2008-08-26 Eli Lilly And Company 3-aryloxy/thio-3-substituted propanamines and their use in inhibiting serotonin and norepinephrine reuptake
US20050004105A1 (en) * 2003-01-29 2005-01-06 Emer Leahy Treatment for a attention-deficit hyperactivity disorder
US20040192730A1 (en) * 2003-03-13 2004-09-30 Dynogen Pharmaceuticals, Inc. Methods of using compounds with combined 5-HT1A and SSRI activities as-needed to treat sexual dysfunction
WO2004087156A1 (en) 2003-04-04 2004-10-14 H. Lundbeck A/S 4-(2-phenylsulfanyl-phenyl)-piperidine derivatives as serotonin reuptake inhibitors
US7160888B2 (en) 2003-08-22 2007-01-09 Warner Lambert Company Llc [1,8]naphthyridin-2-ones and related compounds for the treatment of schizophrenia
KR100872023B1 (ko) * 2003-12-23 2008-12-05 하. 룬트벡 아크티에 셀스카브 Ssri로서 2-(1h-인돌릴술파닐)-벤질 아민 유도체
EP1701940B1 (de) * 2003-12-23 2008-05-28 H.Lundbeck A/S 2-(1h-indolylsulfanyl)-benzylaminderivate als ssri
TWI347183B (en) * 2003-12-23 2011-08-21 Lundbeck & Co As H 2-(1h-indolylsulfanyl)-benzyl amine derivatives
AR052308A1 (es) 2004-07-16 2007-03-14 Lundbeck & Co As H Derivados de 2-(1h-indolilsulfanil)-arilamina y una composicion farmaceutica que contiene al compuesto
AR054393A1 (es) 2005-06-17 2007-06-20 Lundbeck & Co As H Derivados de benzo(b)furano y benzo(b)tiofeno, composiciones farmaceuticas que los contienen y su uso en la fabricacion de un medicamento para el tratamiento de enfermedades mediadas por la inhibicion de la reabsorcion de neurotransmisores de amina biogenicos.
US7629473B2 (en) 2005-06-17 2009-12-08 H. Lundbeck A/S 2-(1H-indolylsulfanyl)-aryl amine derivatives
US7994220B2 (en) * 2005-09-28 2011-08-09 Cypress Bioscience, Inc. Milnacipran for the long-term treatment of fibromyalgia syndrome
ZA200901739B (en) * 2006-09-28 2010-06-30 Lundbeck & Co As H [2-(6-flouro-1H-indol-3-ylsulfanyl)benzyl]methyl amine for the treatment of affective disorders
US10154988B2 (en) 2012-11-14 2018-12-18 The Johns Hopkins University Methods and compositions for treating schizophrenia

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5013761A (en) * 1988-06-03 1991-05-07 Eli Lilly And Company Serotonin antagonists
US5627196A (en) * 1995-01-17 1997-05-06 Eli Lilly And Company Compounds having effects on serotonin-related systems
US5614523A (en) * 1995-01-17 1997-03-25 Eli Lilly And Company Compounds having effects on serotonin-related systems
US5576321A (en) * 1995-01-17 1996-11-19 Eli Lilly And Company Compounds having effects on serotonin-related systems

Also Published As

Publication number Publication date
ES2160894T3 (es) 2001-11-16
GR3037072T3 (en) 2002-01-31
AU3401797A (en) 1998-01-07
DE69706000D1 (de) 2001-09-13
DK0814084T3 (da) 2001-10-08
WO1997048698A1 (en) 1997-12-24
US5912256A (en) 1999-06-15
EP0814084B1 (de) 2001-08-08
JP2000513358A (ja) 2000-10-10
HK1008525A1 (en) 1999-05-14
PT814084E (pt) 2001-11-30
DE69706000T2 (de) 2002-04-04
EP0814084A1 (de) 1997-12-29
CA2257962A1 (en) 1997-12-24

Similar Documents

Publication Publication Date Title
DE69706000D1 (de) Indolderivat als 5-HT1A Antagonist und als Inhibitor der Serotonin-Wiederaufnahme
EA199700156A1 (ru) Производные индола как антагонисты рецептора 5-нт
NO20044514L (no) Indan- eller dihydroindolderivater
DE60142921D1 (de) Azaphenanthridone-derivate und deren verwendung als parp-inhibitoren
BR0007595A (pt) 4-(heterociclisulfonamido)-5-metóxi-6-(2-metoxifenó xi)-2-fenil-ou piridilpirimidinas como antagonistas de receptor de endotelina
FI970150A0 (fi) Substituoituja pyrimidiiniyhdisteitä ja niiden käyttö
AR028817A1 (es) Compuestos derivados de la 1-arenosulfonil-2-arilo-pirrolidina, su empleo, un procedimiento para obtenerlos y medicamentos que los contienen
EA200301073A1 (ru) N-(2-арилэтил)бензиламины в качестве антагонистов 5-ht-рецептора
BR9712085A (pt) Inibidores de metaloprotease heterocìclicos
DE69819173D1 (de) Indole und 2,3-dihydroindolderivate, ihre herstellung und verwendung
ES2111639T3 (es) Derivados de 3-aminopiperidina y heterociclos relacionados que contienen nitrogeno.
CY1105686T1 (el) 2-(ΠΥΡΙΔΙΝ-2-ΥΛΑΜΙΝΟ)-ΠΥΡΙΔΟ[2,3-d]ΠΥΡΙΜΙΔΥΝ-7-ΟΝΕΣ
ATE496620T1 (de) 1h-benzo(f)indazol-5-yl-derivate als selektive glucocorticoid-rezeptor-modulatoren
EA199901114A1 (ru) Полиморфная форма 2-(r)-(1-(r)-(3,5-бис(трифторметил)фенил)этокси)-3-(s)-(4-фтор)фенил-4-(3-(5-оксо-1h,4h-1,2,4-триазоло)метилморфолина в качестве антагониста рецептора тахикина
DE602005010970D1 (de) Indol-derivate und ihre verwendung als kinase-hemmer, insbesondere ikk2-hemmer
ATE256671T1 (de) 2-phenyl-substituierte 1-(n-phenylaminoalkyl)- piperazin-derivate
ATE270271T1 (de) Sulfonamidhydroxamate
ATE210649T1 (de) Arylacrylamidderivate als 5ht1 agoniste oder antagoniste
DE60010758D1 (de) Piperidin-derivate und ihre verwendung als serotonin rezeptor antagonisten
BR9916618A (pt) Compostos heterocìclicos antidepressivos
DE602006010540D1 (de) (3,4-dihydro-chinazolin-2-yl)-(2-aryloxy-ethyl)-amine mit aktivität am 5-ht-rezeptor
DE60131001D1 (de) Oxazolylarylpropionsäure derivate und ihre verwendung als ppar agonisten
ATE254122T1 (de) Indolderivate als 5-ht1b und 5-ht1d agonisten
DE602004024033D1 (de) 8-azabicycloä3.2.1üoctanderivate und ihre verwendung als monoamine-neurotransmitter-reuptake inhibitoren
Abate et al. Interaction of chiral MS-245 analogs at h5-HT6 receptors

Legal Events

Date Code Title Description
REN Ceased due to non-payment of the annual fee